Exclusive

Publication

Byline

Location

US Patent Issued to Novartis on Aug. 11 for "Pharmaceutical products and stable liquid compositions of IL-17 antibodies" (Swiss Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,711, issued on Aug. 11, was assigned to Novartis AG (Basel, Switzerland). "Pharmaceutical products and stable liquid compositions of IL-17 ... Read More


US Patent Issued to THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION on Aug. 11 for "Enteroendocrine cell-targeting polymer substance conjugated with photosensitizer, and medical use thereof for ameliorating metabolic disease" (South Korean Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,712, issued on Aug. 11, was assigned to THE CATHOLIC UNIVERSITY OF KOREA INDUSTRY-ACADEMIC COOPERATION FOUNDATION (Seoul, South Korea). "En... Read More


US Patent Issued to onCour Pharma on Aug. 11 for "Treatment of immune evasive tumors" (Illinois Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,714, issued on Aug. 11, was assigned to onCour Pharma Inc. (Northbrook, Ill.). "Treatment of immune evasive tumors" was invented by John Pu... Read More


US Patent Issued to University of Florida Research Foundation on Aug. 11 for "Targeted RNA degradation allows precision repurposing of protein-targeted small molecule medicines to RNA" (Florida Inventor)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,715, issued on Aug. 11, was assigned to University of Florida Research Foundation Inc. (Gainesville, Fla.). "Targeted RNA degradation allow... Read More


US Patent Issued to Academia Sinica on Aug. 11 for "Monocyte-specific aptamers and uses thereof for delivering therapeutic agents to heart" (Taiwanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,716, issued on Aug. 11, was assigned to Academia Sinica (Taipei, Taiwan). "Monocyte-specific aptamers and uses thereof for delivering thera... Read More


US Patent Issued to National University Corporation Tokai National Higher Education, Sowakai Medical Foundation on Aug. 11 for "Anti-MEFLIN antibody for use in treatment of cancer in subject having cancer, and pharmaceutical composition comprising the antibody" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,717, issued on Aug. 11, was assigned to National University Corporation Tokai National Higher Education (Nagoya, Japan) and Sowakai Medical ... Read More


US Patent Issued to THE UNIVERSITY OF TOKYO on Aug. 11 for "Protein-enclosing polymeric micelle" (Japanese Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,718, issued on Aug. 11, was assigned to THE UNIVERSITY OF TOKYO (Tokyo). "Protein-enclosing polymeric micelle" was invented by Horacio Cabr... Read More


US Patent Issued to NORTHWESTERN UNIVERSITY on Aug. 11 for "Hairpin-like oligonucleotide-conjugated spherical nucleic acid" (Illinois, Michigan Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,719, issued on Aug. 11, was assigned to NORTHWESTERN UNIVERSITY (Evanston, Ill.). "Hairpin-like oligonucleotide-conjugated spherical nuclei... Read More


US Patent Issued to St. Jude Children's Research Hospital on Aug. 11 for "Genomic insulator element exhibiting enhancer blocking activities in lymphocytes and uses thereof" (Tennessee Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,720, issued on Aug. 11, was assigned to St. Jude Children's Research Hospital Inc. (Memphis, Tenn.). "Genomic insulator element exhibiting ... Read More


US Patent Issued to University of Utah Research Foundation on Aug. 11 for "Gene therapy for macular degeneration" (Utah Inventors)

ALEXANDRIA, Va., Aug. 12 -- United States Patent no. 12,702,721, issued on Aug. 11, was assigned to University of Utah Research Foundation (Salt Lake City). "Gene therapy for macular degeneration" wa... Read More